Frst raises Opio

● VC WATCH | GRC · Due Diligence & Screening

SEPTEMBER 16, 2026

Opio raises €4M led by Frst

TARGET

Opio

AI-powered financial due diligence software that automatically collects, verifies, and organizes company financial data for transaction services teams at audit and advisory firms.

Deal value	€4M invested
Ownership	VC-backed · Frst, Seedcamp, Global Founders Capital
Capital raised	€4M
Headcount	10 FTEs
Headquarters	Paris, France
Leadership	Olivier Chancé, general manager

INVESTOR

Frst

Share deal Copy details View press release ↗

Frst -> Opio  (2026-09-18)
vc_round | GRC | €4M | announced
Target: AI-powered financial due diligence software that automatically collects, verifies, and organizes company financial data for transaction services teams at audit and advisory firms.
HQ: Paris, France | Ownership: vc-backed
Advisors - not yet credited
Source: Thematic - https://thematichq.com/software/d/frst-opio.html

Spotted an error or advised on this transaction? Claim credit or send a correction

MORE IN GRC

QED Investors leads a round in FootprintVC Watch AML & Financial CrimeSEP 16

$25M Invested · Footprint – AML, KYC, KYB, transaction monitoring, and enhanced due diligence workflows for FDIC- and OCC-regulated banks and fintechs, delivered via an agentic AI operating system called Percy ›

General Catalyst leads a round in ComplirVC Watch Policy & Regulatory ChangeSEP 16

$11M Invested · Complir – AI infrastructure platform that automates product compliance workflows—labelling, testing, risk scoring, and regulatory monitoring—for retailers and consumer brands selling physical products across international markets ›

Spectrum Equity leads a round in XapienVC Watch Due Diligence & ScreeningSEP 15

$56m Invested · Xapien – AI-native due diligence SaaS platform that automates background investigations on individuals and organizations for compliance, legal, and procurement teams at law firms, banks, universities, and corporates ›

Browse the full register →

SEARCH CONTACT

Thematic is a news publication, not an investment adviser. Nothing here is investment advice or a recommendation to buy or sell any security. Researched and compiled by Thematic; accuracy and completeness are not guaranteed.